 |
PEGylated recombinant anti-Pseudomonas aeruginosa PcrV Fab’ antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2013-10-25 00:00:00 |
| Sponsor | KaloBios Pharmaceuticals, Inc.;442 Littlefield Avenue;South San Francisco, California, 94080 |
Related Access Program